New protein-protein interaction modulators for the therapeutic regulation of synapse dysfunction in neurodevelopmental disorders and neurodegeneration
Alicia Mansilla(Universidad de Alcalá), María José Sánchez-Barrena(Consejo Superior de Investigaciones Científicas), Alberto Ferrús(Consejo Superior de Investigaciones Científicas), Loreto Martínez‐González(Consejo Superior de Investigaciones Científicas), Ruth Pérez‐Fernández(University of Cambridge), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Miguel Daniel-Mozo, Lourdes Infantes(Consejo Superior de Investigaciones Científicas), Andrea Canal-Martín, Nuria E. Campillo(Centro de Investigaciones Biológicas Margarita Salas), Carlos Roca(Centro de Investigaciones Biológicas Margarita Salas), Antonio Chaves-Sanjuán(Consejo Superior de Investigaciones Científicas)
DIGITAL.CSIC (Spanish National Research Council (CSIC))
July 20, 2019
Cited by 0
Related Papers
Monoclonal antibodies against the Drosophila nervous system.
|Proceedings of the National Academy of Sciences|1982|534
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
Shaker encodes a family of putative potassium channel proteins in the nervous system of Drosophila.
|The EMBO Journal|1988|445
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348